DIVISLAB

Pharmaceuticals

Divi's Laboratories Ltd.

NSE: DIVISLABBSE: 532488ISIN: INE361B01024
₹7,248.50
-56.50 · -0.77%
As of 24 Jul 2026
Open
₹7,230.00
High
₹7,280.00
Low
₹7,177.00
Prev Close
₹7,305.00
52W High
₹7,438.50
52W Low
₹5,636.50
Volume
3.29 L
Mkt Cap
₹1.92L Cr
Fundamentals
Valuation & profitability
Market Cap
₹1.92L Cr
P/E Ratio
75
EPS (TTM)
₹96.65
Book Value
₹511.00
Dividend Yield
0.66%
ROCE
16.5%
ROE
12.2%
Sales Growth
4%
Face Value
₹2.00
Company overview
Divi's Laboratories Ltd.

Divis Laboratories was established in 1990; it manufactures the Active Pharma Ingredients (APIs) and intermediates. It focuses on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company has expanded its breadth of working operations in a short period with the purpose to provide complete turnkey solutions to the Indian Pharmaceutical Industry.

And with the five years of experience, and expertise, and a proven track–a record of helping many companies with its turnkey and consulting strengths, it had also established its first manufacturing facility in 1995. Its manufacturing plant is built on a 300-acre site at Hyderabad and its second manufacturing plant is located in Vishakhapatnam on a 314-acre site. It also has a presence in both New Jersey as well as Switzerland.

Currently, both the facilities are engaged in the manufacture of given components:

Active Pharmaceutical Ingredients (APIs) & Intermediates for Generics

The Custom Synthesis of API's and Advanced intermediates for discovery compounds for pharma giants

The Company in Hyderabad has also been successfully inspected by the US FDA during September 2000, in April 2004 and even in February 2008. Whereas it's Unit–2 is situated at Visakhapatnam and was also successfully inspected by the US FDA during November 2006 and in April 2009. It also undertakes various FTE/Contract Research on process development for the discovery of new compounds for the leading M.N.C.s across the globe and their consecutive partners for the supply of APIs. The company is global in its outlook & it benchmarks the quality standards, which are the best in the world.

Key highlights
Auto-generated from live data
  • Trades at a P/E of 75, with a return on equity (ROE) of 12.2%.
  • DIVISLAB is trading above 4 of 5 of its key moving averages (10/20/50/100/200-DMA) — a bullish technical setup.
  • Year-to-date it is up 15.95%, and up 12.8% over the past year.
  • At ₹7,248.50 it sits about 89% of the way up its 52-week range (₹5,636.50–₹7,438.50).
  • Offers a dividend yield of 0.66%.
  • Market capitalisation stands at ₹1.92L Cr.
Price chart
Daily candles + volume · SMA 20 / 50 / 200 · stored OHLC
Shareholding pattern

Shareholding data syncs daily.

Performance
Stock returns vs Nifty 50
10D
+5.73%
Nifty -0.64%
20D
+8.17%
Nifty -1.72%
50D
+12.02%
Nifty +2.68%
100D
+19.73%
Nifty -1.14%
200D
+15.13%
Nifty -8.93%
YTD
+15.95%
Nifty -8.59%
52W
+12.80%
Nifty -7.86%
Moving averages
Simple moving averages vs current price
4/5 above · Bullish
SMA 10-Day
₹7,255.15Below
SMA 20-Day
₹6,985.30Above
SMA 50-Day
₹6,826.63Above
SMA 100-Day
₹6,550.31Above
SMA 200-Day
₹6,454.10Above
Price ranges
Where the price sits in each window
10-Day range₹7,248.50
₹6,786.50₹7,438.50
20-Day range₹7,248.50
₹6,530.50₹7,438.50
50-Day range₹7,248.50
₹6,450.50₹7,438.50
200-Day range₹7,248.50
₹5,647.50₹7,438.50
YTD range₹7,248.50
₹5,647.50₹7,438.50
52-Week range₹7,248.50
₹5,636.50₹7,438.50
Technical signals
Unfilled gaps acting as support / resistance
Unfilled Gap Up On 21 Aug, 2024 : 4734.95 ~ 4728.85SUPPORT
Unfilled Gap Up On 27 May, 2024 : 4215.60 ~ 4175.00SUPPORT
Unfilled Gap Up On 29 Oct, 2018 : 1324.85 ~ 1278.40SUPPORT
Unfilled Gap Up On 02 Nov, 2017 : 1016.00 ~ 933.45SUPPORT
Unfilled Gap Up On 28 Aug, 2017 : 678.40 ~ 676.00SUPPORT
Annual financials
Revenue, profit & EPS by financial year
YearRevenueNet ProfitEPSNPM
Mar 2023₹7,625 Cr₹1,808 Cr₹68.1123.71%
Mar 2022₹8,960 Cr₹2,960 Cr₹111.5233.04%
Mar 2021₹6,969 Cr₹1,984 Cr₹74.7528.47%
Mar 2021₹6,969 Cr₹1,984 Cr₹74.7528.47%
Mar 2020₹5,394 Cr₹1,377 Cr₹51.8525.53%
Mar 2020₹5,394 Cr₹1,377 Cr₹51.8525.53%
Mar 2019₹4,946 Cr₹1,353 Cr₹50.9627.36%
Mar 2019₹4,946 Cr₹1,353 Cr₹50.9627.36%
Mar 2018₹3,891 Cr₹877 Cr₹33.0422.54%
Mar 2017₹4,064 Cr₹1,060 Cr₹39.9526.08%
Mar 2016₹3,776 Cr₹1,126 Cr₹42.4129.82%
Mar 2015₹3,115 Cr₹852 Cr₹60.0827.35%
Peer comparison
Other companies in Pharmaceuticals
CompanyP/EBook ValueSales Growth
SUNPHARMA
SUN PHARMACEUTICAL INDUSTRIES LTD.
39.1₹98.3310.1%
MARKSANS
MARKSANS PHARMA LTD.
23.8₹11.855.8%
MOREPENLAB
MOREPEN LABORATORIES LTD.
20.81₹6.4316.6%
NEULANDLAB
NEULAND LABORATORIES LTD.
23.48₹542.169.35%
GUFICBIO
Gufic BioSciences Ltd.
24.16₹10.8520.41%
DRREDDY
DR.REDDY'S LABORATORIES LTD.
19.73₹852.691.07%
RPGLIFE
RPG LIFE SCIENCES LTD.
17.14₹105.025.73%
GLAND
Gland Pharma Ltd
53.6₹242.00
ZYDUSLIFE
Zydus Lifesciences Ltd
8.23₹166.005%
SMSPHARMA
SMS PHARMACEUTICALS LTD.
9.58₹42.07-8.73%
CIPLA
CIPLA LTD.
15.36₹209.710.7%
Dividend history
Per share, by ex-date
Ex-Date: 11 Aug 2022₹30.00
Ex-Date: 17 Aug 2021₹20.00
Ex-Date: 25 Feb 2020₹16.00
Ex-Date: 14 Aug 2019₹16.00
Ex-Date: 31 Aug 2018₹10.00
Ex-Date: 15 Sept 2017₹10.00
Ex-Date: 17 Mar 2016₹10.00
Ex-Date: 06 Aug 2015₹20.00
Ex-Date: 31 Jul 2014₹20.00
Ex-Date: 25 Jul 2013₹15.00
Ex-Date: 26 Jul 2012₹13.00
Ex-Date: 16 Jun 2011₹10.00
Bulk & block deals
Recent large transactions
DateClientTypeQtyPrice
25 Oct 2022ISHARES CORE EMERGING MARKETS MAURITIUS COSALE1,12,509₹3,612.00
25 Oct 2022ISHARES CORE MSCI EMERGING MARKETS ETFPURCHASE1,12,509₹3,612.00
17 Oct 2022ISHARES CORE EMERGING MARKETS MAURITIUS COSALE1,76,805₹3,572.80
17 Oct 2022ISHARES CORE MSCI EMERGING MARKETS ETFPURCHASE1,76,805₹3,572.80
11 Oct 2022ISHARES CORE EMERGING MARKETS MAURITIUS COSALE1,72,889₹3,686.60
11 Oct 2022ISHARES CORE MSCI EMERGING MARKETS ETFPURCHASE1,72,889₹3,686.60
19 Sept 2022ISHARES CORE EMERGING MARKETS MAURITIUS COSALE1,17,596₹3,573.70
19 Sept 2022ISHARES CORE MSCI EMERGING MARKETS ETFPURCHASE1,17,596₹3,573.70
01 Aug 2022ISHARES INDIA INDEX MAURITIUS COMPANYSALE1,56,778₹3,831.65
01 Aug 2022ISHARES MSCI INDIA ETFPURCHASE1,56,778₹3,831.65
18 Jul 2022ISHARES INDIA 50 ETFPURCHASE20,608₹3,727.75
18 Jul 2022ISHARES INDIA INDEX MAURITIUS COMPANYSALE1,57,719₹3,727.75

Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.